RAS-inhibitors and COVID-19 risk.

29 June 2021 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail

COVID-19 related heart failure: from systemic infection to cardiac inflammation.

Professor M. Metra (Milan, IT)

Presentation thumbnail

COVID-19 in patients with chronic heart failure: management and prognosis.

Professor Y. Zhang (Beijing, CN)

Presentation thumbnail

COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice - discussion.

Access the full session

Session thumbnail

COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice

The Event

Heart Failure 2021

29 June - 1 July 2021

You may be interested in

Congress Presentation

Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy

Congress Presentation

Presence of heart failure in pts with coronary artery disease and artery hypertension

Congress Session

Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources